Literature DB >> 1081686

[Is triacetyl oleandomycin-ergotamine tartrate combination dangerous?].

B Bigorie, P Aimez, R J Soria, F Samama, G di Maria, B Guy-Grand, H Bour.   

Abstract

The authors report a case of ischaemia of all four limbs in an adolescent following the simultaneous ingestion of triacetyl oleandomycin and ergotamine tartrate in low dosage. Two cases involving this same association of medications have appeared in the literature and attention is therefore drawn to the possible danger of use of these two drugs together.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1081686

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  5 in total

Review 1.  Clinically significant drug interactions with agents specific for migraine attacks.

Authors:  M J Eadie
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Side-effects due to the intravenous infusion of erythromycin lactobionate.

Authors:  R Putzi; J Blaser; R Lüthy; R Wehrli; W Siegenthaler
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

3.  Effects of josamycin on carbamazepine kinetics.

Authors:  G Vinçon; H Albin; F Demotes-Mainard; M Guyot; C Bistue; P Loiseau
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

4.  Severe vascular spasm due to erythromycin-ergotamine interaction.

Authors:  H Francis; A Tyndall; J Webb
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

5.  Interaction of dihydroergotamine and triacetyloleandomycin in the minipig.

Authors:  M Martinet; J R Kiechel
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983 Jul-Sep       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.